CSL full year net profit jumps 28 per cent

Company News

by Anna Napoli

CSL (ASX:CSL) has reported its net profit after tax (NPAT) rose about 28 per cent on FY17 to $1.7 billion for the 2018 financial year.

CSL’s profit result was in line with UBS expectations.

In more good news for the biotech company, its revenue strengthened over the 2018 financial year, and lifted 11 per cent on FY16 to $7.9 billion.

Its earnings before interest and tax (EBIT) increased over 33 per cent on the prior year, to around $2.4 billion.

The company declared a total full year dividends of $1.72 per share a rise of 26 per cent on last year.

CSl says net profit for the 2019 financial year is expected to be in the range of $1.88 to $1.95 billion a rise of 10 14 per cent on this year’s result.

Shares in CSL (ASX:CSL) is trading 0.52 per cent higher to $202.74.

Anna Napoli

Finance News Network
Anna joined FNN February 2018 and also works with Channel 7 as a freelance producer. Anna has also worked as a lawyer and lecturer. She has also presented news updates for interstate news with Southern Cross Austereo.